These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30100179)

  • 1. Progressive cerebello-cerebral atrophy and progressive encephalopathy with edema, hypsarrhythmia and optic atrophy may be allelic syndromes.
    Hady-Cohen R; Ben-Pazi H; Adir V; Yosovich K; Blumkin L; Lerman-Sagie T; Lev D
    Eur J Paediatr Neurol; 2018 Nov; 22(6):1133-1138. PubMed ID: 30100179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2).
    Feinstein M; Flusser H; Lerman-Sagie T; Ben-Zeev B; Lev D; Agamy O; Cohen I; Kadir R; Sivan S; Leshinsky-Silver E; Markus B; Birk OS
    J Med Genet; 2014 May; 51(5):303-8. PubMed ID: 24577744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy (PEHO) syndrome in a Swiss child.
    Klein A; Schmitt B; Boltshauser E
    Eur J Paediatr Neurol; 2004; 8(6):317-21. PubMed ID: 15542387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel homozygous nonsense mutation in CCDC88A gene cause PEHO-like syndrome in consanguineous Saudi family.
    Abdulkareem AA; Abulnaja KO; Jan MM; Karim S; Rasool M; Ansari SA; Chaudhary AG; Al-Qahtani MH; Naseer MI
    Neurol Sci; 2019 Feb; 40(2):299-303. PubMed ID: 30392057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome) in two Japanese siblings.
    Fujimoto S; Yokochi K; Nakano M; Wada Y
    Neuropediatrics; 1995 Oct; 26(5):270-2. PubMed ID: 8552220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epilepsy and the electroencephalogram in progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (the PEHO syndrome).
    Somer M; Sainio K
    Epilepsia; 1993; 34(4):727-31. PubMed ID: 8330584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VPS53 gene is associated with a new phenotype of complicated hereditary spastic paraparesis.
    Hausman-Kedem M; Ben-Shachar S; Menascu S; Geva K; Sagie L; Fattal-Valevski A
    Neurogenetics; 2019 Oct; 20(4):187-195. PubMed ID: 31418091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.
    Nevanlinna V; Konovalova S; Ceulemans B; Muona M; Laari A; Hilander T; Gorski K; Valanne L; Anttonen AK; Tyynismaa H; Courage C; Lehesjoki AE
    Eur J Med Genet; 2020 Mar; 63(3):103766. PubMed ID: 31536827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCDC88A mutations cause PEHO-like syndrome in humans and mouse.
    Nahorski MS; Asai M; Wakeling E; Parker A; Asai N; Canham N; Holder SE; Chen YC; Dyer J; Brady AF; Takahashi M; Woods CG
    Brain; 2016 Apr; 139(Pt 4):1036-44. PubMed ID: 26917597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEHO syndrome: the endpoint of different genetic epilepsies.
    Chitre M; Nahorski MS; Stouffer K; Dunning-Davies B; Houston H; Wakeling EL; Brady AF; Zuberi SM; Suri M; Parker APJ; Woods CG
    J Med Genet; 2018 Dec; 55(12):803-813. PubMed ID: 30287594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
    Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
    Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEHO Syndrome May Represent Phenotypic Expansion at the Severe End of the Early-Onset Encephalopathies.
    Gawlinski P; Posmyk R; Gambin T; Sielicka D; Chorazy M; Nowakowska B; Jhangiani SN; Muzny DM; Bekiesinska-Figatowska M; Bal J; Boerwinkle E; Gibbs RA; Lupski JR; Wiszniewski W
    Pediatr Neurol; 2016 Jul; 60():83-7. PubMed ID: 27343026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome).
    Shevell MI; Colangelo P; Treacy E; Polomeno RC; Rosenblatt B
    Pediatr Neurol; 1996 Nov; 15(4):337-9. PubMed ID: 8972535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dutch patients with progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO) syndrome.
    Vanhatalo S; Somer M; Barth PG
    Neuropediatrics; 2002 Apr; 33(2):100-4. PubMed ID: 12075493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low insulin-like growth factor (IGF-1) in the cerebrospinal fluid of children with progressive encephalopathy, hypsarrhythmia, and optic atrophy (PEHO) syndrome and cerebellar degeneration.
    Riikonen R; Somer M; Turpeinen U
    Epilepsia; 1999 Nov; 40(11):1642-8. PubMed ID: 10565594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile cerebello-optic atrophy. Neuropathology of the progressive encephalopathy syndrome with edema, hypsarrhythmia and optic atrophy (the PEHO syndrome).
    Haltia M; Somer M
    Acta Neuropathol; 1993; 85(3):241-7. PubMed ID: 8460530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar granule neuron loss.
    Anttonen AK; Laari A; Kousi M; Yang YJ; Jääskeläinen T; Somer M; Siintola E; Jakkula E; Muona M; Tegelberg S; Lönnqvist T; Pihko H; Valanne L; Paetau A; Lun MP; Hästbacka J; Kopra O; Joensuu T; Katsanis N; Lehtinen MK; Palvimo JJ; Lehesjoki AE
    Brain; 2017 May; 140(5):1267-1279. PubMed ID: 28335020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic features of PEHO and PEHO-Like syndromes: A scoping review.
    Sabaie H; Ahangar NK; Ghafouri-Fard S; Taheri M; Rezazadeh M
    Biomed Pharmacother; 2020 Nov; 131():110793. PubMed ID: 33152950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEHO and PEHO-like syndromes: report of five Australian cases.
    Field MJ; Grattan-Smith P; Piper SM; Thompson EM; Haan EA; Edwards M; James S; Wilkinson I; Adès LC
    Am J Med Genet A; 2003 Sep; 122A(1):6-12. PubMed ID: 12949965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEHO syndrome caused by compound heterozygote variants in ZNHIT3 gene.
    Õunap K; Muru K; Õiglane-Shlik E; Ilves P; Pajusalu S; Kuus I; Wojcik MH; Reimand T
    Eur J Med Genet; 2020 Feb; 63(2):103660. PubMed ID: 31048081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.